Dr Karsten Eastman, CEO, Sethera Therapeutics, highlights the challenges around ‘true’ diversification in DNA libraries.
WEST LAFAYETTE, Ind. — More than a decade ago, scientists harnessed a bacterial molecular machine that identifies and cuts specific sections of DNA, revolutionizing the ability to edit genes and ...
A new gene-editing technique enables the correction of multiple genetic mutations simultaneously, transforming the prospects for millions living with complex inherited diseases, such as cystic ...
Mission Bio, a leader in single-cell multi-omics solutions for precision medicine, today announced its Tapestri® Single-Cell Targeted DNA + RNA Assay, the first commercial platform to measure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results